THE EPIDEMIOLOGICAL, CLINICAL, AND PARACLINICAL CHARACTERISTICS, AS WELL AS TREATMENT OUTCOMES, OF NEONATAL PNEUMONIA CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) AT PHU THO OBSTETRICS AND PEDIATRICS HOSPITAL

Đức Hậu Nguyễn, Thị Hà Dương, Thị Như Quỳnh Nguyễn, An Dương Hoàng

Main Article Content

Abstract

Objective: To describe the epidemiological, clinical, and paraclinical characteristics, as well as treatment outcomes, of neonatal pneumonia caused by respiratory syncytial virus (RSV) at Phu Tho Obstetrics and Pediatrics Hospital. Methods: A descriptive study combining retrospective and prospective data collection was conducted on 142 neonates aged 28 days or younger who were diagnosed with RSV pneumonia and treated at the Neonatal Department of Phu Tho Obstetrics and Pediatrics Hospital from August 2022 to July 2024.    Results: The proportions of male and female patients were 48.59% and 51.41%, respectively. RSV pneumonia occurred throughout the year, with a peak from October to December. The most common clinical manifestations were cough (99.3%), wheezing (97.2%), and abnormal lung auscultation findings (96.5%). Chest radiographs mainly showed interstitial lesions (37.3%) and alveolar opacities (35.9%). Most patients had a normal white blood cell count, while lymphocytosis was more common than neutrophilia. Respiratory distress was observed in 40.85% of cases, and oxygen therapy was the most frequently used respiratory support modality (44.4%). Antibiotics were administered in all cases. The recovery rate was 98.6%, and the mean length of hospital stay was 8.3 days. Conclusion: RSV pneumonia in neonates mainly presents with respiratory manifestations, whereas systemic inflammatory signs are uncommon. Interstitial and alveolar abnormalities are the most frequent chest X-ray findings. Although respiratory distress is common and many patients require respiratory support, treatment outcomes are generally favorable with timely diagnosis, close monitoring, and appropriate supportive care.

Article Details

References

1. Ruuskanen O, Lahti E, Jennings L, et al. (2011), "Viral pneumonia", The Lancet, 377(9773), 1264-1275.
2. Shi T, McAllister D.A, O’Brien K.L, et al. (2017), "Global, regional and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015", The Lancet.
3. Hall C.B. (2001), "Respiratory syncytial virus and parainfluenza virus", New England Journal of Medicine, 344(25), 1917-1928.
4. Tran D.N, Pham T.M.H, Ha M.T, et al. (2013), "Molecular epidemiology and disease severity of human respiratory syncytial virus in Vietnam", PLoS One, 8(1), e45436.
5. World Health Organization (2013), Pocket book of hospital care for children: guidelines for the management of common childhood illnesses, WHO, Geneva.
6. Cho H.J, Shim S.Y, Sun D.W, et al. (2013), "Respiratory viruses in neonates hospitalized with acute lower respiratory tract infections", Pediatrics International, 55(1), 49-53.
7. Lưu Thị Hoa (2017), "Đặc điểm dịch tễ học lâm sàng của trẻ sơ sinh viêm phổi có nhiễm virus hợp bào hô hấp tại Bệnh viện Nhi Trung ương", Luận văn Thạc sỹ, Đại học Y Hà Nội.
8. Lê Thị Ngọc Anh (2018), "Kết quả điều trị nhiễm virus hợp bào hô hấp ở trẻ sơ sinh và một số yếu tố liên quan tại Bệnh viện Nhi Trung ương năm 2017-2018", Luận văn Thạc sỹ, Đại học Y Dược Hải Phòng.
9. Huỳnh Lê Ngọc Diễm, Nguyễn Minh Phương, Nguyễn Thị Thu Cúc (2020), "Tình hình nhiễm RSV ở bệnh viêm tiểu phế quản cấp ở trẻ em dưới 2 tuổi tại Bệnh viện Nhi Đồng Cần Thơ năm 2019-2020", Tạp chí Y học Cần Thơ, 30, 3.
10. Đào Thị Mai Thanh, Đào Minh Tuấn (2005), "Nghiên cứu đặc điểm dịch tễ, lâm sàng, cận lâm sàng nhiễm trùng hô hấp cấp do virus hợp bào hô hấp tại Khoa Hô hấp Bệnh viện Nhi Trung ương", Tạp chí Nghiên cứu Y học, 38, 214-218.